Plus Therapeutics, Inc. Gains 24.18%

Plus Therapeutics, Inc. (PSTV:NASDAQ) jumped higher at $3.03, representing a gain of 24.2%. On Mon 14 Sep 20, PSTV:NASDAQ touched a New 2-Week Low of $2.44. The stock appeared on our News Catalysts scanner on Tue 15 Sep 20 at 07:32 AM in the 'BIOTECH' category. From Mon 31 Aug 20, the stock recorded 33.33% Up Days and 50.00% Green Days

The stock spiked on Fri 07 Aug 20 at $3.56 with a volume of 4M+, and its share price has been moving sideways in recent weeks.

About Plus Therapeutics, Inc. (PSTV:NASDAQ)

Cytori Therapeutics Inc is a specialty therapeutics company. It focuses to provide meaningful and quality therapeutic options with a broad utility that benefit patients and healthcare providers. The company has two therapeutic development platforms: Cytori Cell Therapy (CCT) and Cytori Nanomedicine. The CCT platform is based on the scientific discovery that the human adipose or fat tissue compartment is a source of a mixed population of stem, progenitor and regenerative cells. The Cytori Nanomedicine Platform features a versatile and novel protein-stabilized liposomal nanoparticle technology for drug encapsulation that provides the foundation to bring two drugs into early/ late-stage clinical trials.